Dr. Agarwal's Health Care Limited
AGARWALEYE.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$150.24B
Close$
$77.71
83.6% downside
Current Fair Value
83.6% downsideOvervalued by 83.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $150.24 Billion |
|---|---|
| Enterprise Value | $150.24 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.21 |
| Beta | 0.76 |
| Outstanding Shares | 316,293,706 |
Return
| Return on Equity | 7.00% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 101.04 |
|---|---|
| PEG | 200.03 |
| Price to Sales | 6.87 |
| Price to Book Ratio | 7.07 |
| Enterprise Value to Revenue | 6.81 |
| Enterprise Value to EBIT | 43.5 |
| Enterprise Value to Net Income | 101 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$1.16
Average shareholder expectationRevenue Estimate
$5.93 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$1.33
Average shareholder expectationRevenue Estimate
$6.14 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dr. Agarwal's Health Care Limited
4,214 employees
CEO: Adil Agarwal Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within India and abroad. The company delivers a comprehensive range of ophthalmic services, including advanced surgical solutions for cataracts like small incision, ...